Injective (INJ) price experiences volatility amid market selling pressure

Injective (INJ) has faced recent price declines, trading at approximately $7.09 on October 31, 2026, representing a 4.09% drop over a 24-hour period. This decline appears to be part of broader selling pressure affecting mid-cap cryptocurrency assets rather than being driven by a specific protocol-level catalyst.

Market data shows mixed signals. While spot trading volume was reported at roughly $100 million, on-chain and spot venue activity was significantly lower, at approximately $8.7 million. In the derivatives market, the funding rate for INJ perpetual contracts was reported at a neutral level, with some data indicating a shift from negative to slightly positive funding rates.

Technical indicators present a neutral to cautious outlook. The Relative Strength Index (RSI) was recorded at 41.08, placing it in a neutral zone, while various moving averages, including the 10-day and 20-day simple moving averages, remained above the recent closing price.